semaglutide diabetes study united states Effects of with and without concomitant SGLT2 inhibitor use in participants with type 2 and chronic kidney disease in the FLOW trial How Long Has Semaglutide Been

The period during active fat loss is when tissue remodeling is biologically primed to respond to stimulus

What to Expect in Months 7-11 Essentially no side effects: Appetite suppression continues (desired effect), but GI symptoms gone Weight loss velocity slows: From 0.8kg/week (months 3-6) to 0.3-0.5kg/week Plateau around week 40-48: Weight stabilizes, no longer losing despite continued medication Total weight loss: Average 20-24% from baseline (matching or exceeding surgical outcomes) Focus shifts to maintenance: Accepting current weight, preventing regain Plateau frustration: Not a side effect but an emotional challenge 2 Final Strategies for Months 7-11 20

The total stays the same

Improved Eating Patterns Throughout treatment, Semaglutide can help you cultivate healthier eating habits by naturally reducing your food intake